|
CCT6P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55251999999217E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.93319999999675E-05 |
| Normal-vs-Stage2 |
1.948460E-02 |
| Normal-vs-Stage3 |
7.908100E-02 |
| Normal-vs-Stage4 |
1.236570E-01 |
| Stage1-vs-Stage2 |
9.006400E-01 |
| Stage1-vs-Stage3 |
1.902970E-01 |
| Stage1-vs-Stage4 |
4.718600E-01 |
| Stage2-vs-Stage3 |
3.495800E-01 |
| Stage2-vs-Stage4 |
5.580600E-01 |
| Stage3-vs-Stage4 |
8.974400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5439399999928E-05 |
| Normal-vs-AfricanAmerican |
1.482860E-03 |
| Normal-vs-Asian |
8.242400E-02 |
| Caucasian-vs-AfricanAmerican |
7.193200E-01 |
| Caucasian-vs-Asian |
7.447200E-01 |
| AfricanAmerican-vs-Asian |
8.630000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58400000000092E-06 |
| Normal-vs-Female |
8.983400E-04 |
| Male-vs-Female |
3.341800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.121500E-03 |
| Normal-vs-Extreme_Weight |
1.212420E-04 |
| Normal-vs-Obese |
1.400170E-04 |
| Normal-vs-Extreme_Obese |
1.809560E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.150000E-01 |
| Normal_Weight-vs-Obese |
4.285800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.161400E-01 |
| Extreme_Weight-vs-Obese |
8.550600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.101800E-01 |
| Obese-vs-Extreme_Obese |
2.560000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.584800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.01600000002033E-06 |
| Normal-vs-Age(61-80Yrs) |
4.156000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.422400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.489000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.028000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.679620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.717900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.218830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.037200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.48319995069346E-09 |
| Normal-VS-Type2 PRCC |
8.937400E-01 |
| Normal-VS-KIRP CIMP |
1.854820E-01 |
| Normal-VS-Unclassified PRCC |
5.518300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.11022302462516E-16 |
| Type1 PRCC-VS-KIRP CIMP |
8.482200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.968000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.475600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.840050E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.916000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.263600E-02 |
| Normal-vs-N1 |
1.760250E-02 |
| Normal-vs-N2 |
6.298200E-01 |
| N0-vs-N1 |
4.573800E-01 |
| N0-vs-N2 |
6.391400E-01 |
| N1-vs-N2 |
4.882000E-01 |
|
|
